Reduction of gut hypoplasia and cachexia in tumor-bearing rats maintained on total parenteral nutrition and treated with peptide YY and clenbuterol

Nutrition

Volumn 14, Issue 6, 1998, Pages 502-507

  Chance, William T ^a   Zhang, X ^a   Zuo, Lee ^a   Balasubramaniam, Ambikaipakam ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Cachexia; Gut atrophy; Parenteral nutrition; PYY

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CLENBUTEROL; PEPTIDE YY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATROPHY; CACHEXIA; FOLLOW UP; GASTROCNEMIUS MUSCLE; HORMONAL THERAPY; MALE; NONHUMAN; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; SMALL INTESTINE;

ADRENERGIC BETA-AGONISTS; ANIMALS; CACHEXIA; CLENBUTEROL; COMBINED MODALITY THERAPY; DRUG SYNERGISM; INTESTINAL MUCOSA; INTESTINE, SMALL; MALE; PARENTERAL NUTRITION, TOTAL; PEPTIDE YY; PROTEINS; RATS; RATS, INBRED F344; SARCOMA, EXPERIMENTAL;

ANIMALIA;

EID: 0032101376     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(98)00038-0     Document Type: Article

References (47)

1. Warren S. The immediate causes of death in cancer. Am J Med Sci. 184:1932;610.
2. DeWys W.D., Begg C., Lavin P.T. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med. 69:1980;491.
3. Lanzotti V.J., Thomas D.R., Boyle L.E., et al. Survival with inoperable lung cancer an integration of prognostic variables based on simple clinical criteria . Cancer. 39:1977;303.
4. Shamberger R.C., Brennan M.F., Goodgame J.T., et al. A prospective, randomized study of adjuvant parenteral nutrition in the treatment of sarcomas results of metabolic and survival studies . Surgery. 96:1984;1.
5. Popp M.B., Morrison S.D., Brennan M.F. Total parenteral nutrition in a methylcholanthrene induced rat sarcoma model. Cancer Treat Rpt. 65:1981;137.
6. Dworkin L.D., Levine G.M., Farber N.J., et al. Small intestine mass of the rat is partially determined by indirect effects of intraluminal nutrition. Gastroenterology. 71:1976;626.
7. Buchman A.L., Moukarzel A.A., Ament M.E., et al. Effects of total parenteral nutrition on intestinal morphology and function in humans. Transplant Proc. 26:1994;1457.
8. Klein S., Simes J., Blackburn G.L. Total parenteral nutrition and cancer clinical trials. Cancer. 58:1986;1378.
9. Christensen M.L., Hancock M.L., Gattuso J., et al. Parenteral nutrition associated with increased infection rate in children with cancer. Cancer. 72:1993;2732.
10. Alverdy J.C., Aoys E., Moss G.S. Total parenteral nutrition promotes bacterial translocation from gut. Surgery. 104:1988;185.
11. Chance W.T., Cao L., Zhang F.S., et al. Clenbuterol treatment increases muscle mass and protein content of tumor-bearing rats maintained on total parenteral nutrition. JPEN. 15:1991;530.
12. Goodlad R.A., Ghatei M.A., Domin J., et al. Plasma enteroglucagon, peptide YY and gastrin in rats deprived of luminal nutrition, and after urogastrone-EGF administration. A proliferative role for PYY in the intestinal epithelium? Experentia. 45:1989;168.
13. Chance W.T., Cao L., Nelson J.L., et al. Acivicin reduces tumor growth during total parenteral nutrition (TPN). Surgery. 102:1987;386.
14. Chance W.T., Zhang X., Balasubramaniam A., et al. Preservation of intestine protein by Peptide YY during total parenteral nutrition. Life Sci. 58:1996;1785.
15. Voisin T., Bens M., Cluzeaud F., et al. Peptide YY receptors in the proximal tubule PKSV-PCT cell line derived from transgenic mice. J Biol Chem. 268:1993;20,547.
16. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc Natl Acad Sci USA. 79:1982;2514.
17. Adrian T.E., Ferri G.L., Bacarese-Hamilton A.J., et al. Human distribution and release of a putative new gut hormone, peptide YY (PYY). Gastroenterol. 89:1985;1070.
18. Balasubramaniam A., Cox H.M., Voisin T., et al. Structure-activity studies of peptide YY(22-36) N-a-Ac[Phe27]PYY(22-36), a potent antisecretory peptide in rat jejunum . Peptides. 14:1993;1011.
19. Chen M.H., Balasubramaniam A., Murphy R.F., et al. A sensitive radioimmunoassay for measurement of circulating peptide YY. Gastroenterol. 87:1984;1332.
20. Hartree E.F. Determination of protein a modification of the Lowry method that gives a linear photometric response . Anal Biochem. 48:1972;422.
21. Rossi T.M., Lee P.C., Young C., et al. Small intestinal mucosa changes, including epithelial cell proliferative activity, of children receiving total parenteral nutrition (TPN). Digest Dis Sci. 38:1993;1608.
22. Alverdy J.C., Burke D.B. Total parenteral nutrition iatrogenic immunosuppression . Nutrition. 8:1992;359.
23. Alverdy J., Chi H.S., Sheldon G.F. The effect of parenteral nutrition on gastrointestinal immunity. Ann Surg. 202:1985;681.
24. Chance W.T., Ogle C.K., Thomas I., et al. Immunostimulation following fish oil-based parenteral nutrition in tumor-bearing rats. Nutr Cancer. 26:1996;303.
25. Stallion A., Foley-Nelson T., Chance W.T., et al. Parenteral vs enteral nutrition in tumor-bearing rats. JPEN. 18:1994;148.
26. Bottcher G., Sjolerg J., Ekman R. Peptide YY in the mammalian pancreas immunocytochemical localization and immunochemical characterization . Regul Pept. 43:1993;115.
27. Jin H., Cai L., Lee K., et al. A physiological role of peptide YY on exocrine pancreatic secretion in rats. Gastroenterology. 105:1993;208.
28. Bertrand G., Gross R., Roye M., et al. Evidence for a direct inhibitory effect of PYY on insulin secretion in rats. Pancreas. 7:1993;595.
29. Andrews N.J., Irving M.H. Human gut hormone profiles in patients with short bowel syndrome. Dig Dis Sci. 37:1992;729.
30. Goodlad R.A., Lenton W., Ghatei M.A., et al. Effects of an elemental diet, inert bulk and different types of dietary fibre on the response of the intestinal epithelium to refeeding in the rat and relationship to plasma gastrin, enteroglucagon and PYY levels. Gut. 28:1987;171.
31. Goodlad R.A., Ghatei M.A., Domin J., et al. Is peptide YY trophic to the intestinal epithelium of parenterally fed rats? Digestion. 46:1990;177.
32. Lundberg J.M., Tatemoto K., Terenius L., et al. Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility. Proc Natl Acad Sci USA. 79:1982;4471.
33. Nials A.T., Coleman R.A., Johnson M., et al. Effects of beta-adrenoceptor agonists in human bronchial muscle. Br J Pharmacol. 110:1993;1112.
34. Bogoyevitch M.A., Andersson M.B., Gillespie-Brown J., et al. Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochem J. 314:1996;115.
35. Larhammar D., Bloomqvist A.G., Yee F., et al. Cloning and functional expression of human neuropeptide Y/peptide YY receptor of Y1 type. J Biol Chem. 267:1992;10,935.
36. Chance W.T., von Allmen D., Benson D., et al. Clenbuterol decreases catabolism and increases hypermetabolism in burned rats. J Trauma. 31:1991;365.
37. Benson D.W., Foley-Nelson T., Chance W.T., et al. Decreased myofibrillar protein breakdown following treatment with clenbuterol. J Surg Res. 50:1991;1.
38. Eadara J.K., Dalrymple R.H., Delay R.L., et al. Effects of cimaterol, a beta-adernergic agonist, on protein metabolism in rats. Metabolism. 38:1989;883.
39. 2-agonist cimaterol in vitro and in tumor-bearing rats. J Surg Res. 59:1995;387.
40. Reeds P.J., Hay S.M., Dorward P.M., et al. Stimulation of muscle growth by clenbuterol lack of effect on muscle protein biosynthesis . Br J Nutr. 56:1986;249.
41. Chance W.T., Foley-Nelson T., Thomas I., et al. Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-II. Am J Physiol. 273:1997;559.
42. Jacobs D.O., Evans D.A., Mealy K., et al. Combined effects of glutamine and epidermal growth factor on the rat intestine. Surgery. 104:1988;358.
43. Ko T.C., Beauchamp R.D., Townsend C.M., et al. Glutamine is essential for epidermal growth factor-stimulated intestinal cell proliferation. Surgery. 114:1993;147.
44. Goodlad R.A., Wilson T.G., Lenton W., et al. The proliferative effects of urogastrone-epidermal growth factor (EGF) on the intestinal epithelium. Gut. 28:1987;S37.
45. Hughes C.A., Bates T., Dowling R.H. Cholecystokinin and secretin prevent the intestinal mucosal hypoplasia of total parenteral nutrition in the dog. Gastroenterology. 75:1978;34.
46. Wood J.G., Hoang H.D., Bussjaeger L.J., et al. Neurotensin stimulates growth of small intestine in rats. Am J Physiol. 255:1988;G813.
47. Iijima S., Toshimasa T., Kido Y., et al. Intravenous administration of nucleosides and a nucleotide mixture diminishes intestinal mucosal atrophy induced by total parenteral nutrition. JPEN. 17:1993;265.